stars 1 stars 2 stars 3

HAPILA GmbH was founded in 2007 as an independent enterprise by scientists and technicians with long-standing experience in the pharmaceutical industry. Since then we have experienced continuous growth and establishment of a successful business organization, international client base and regulatory compliance structure for cGMP-API manufacturing, European certification and grant of European and US patents on our proprietary HAPIpur® technology. As a contract developer and manufacturer (CDMO), HAPILA provides high-value production of active pharmaceutical ingredients (APIs) for pharma, biotech and fine chemicals clients. Our mission is to be highly efficient bridge-builders between API production and pharmaceutical end-use, supplying highest quality, potency and safety products in compliance with Good Manuafacturing Practice (GMP) and environmental guidelines. All HAPILA APIs are manufactured in-house at our GMP certified facility at Gera, Thuringia, in east-central Germany, where our highly qualified team is focused on product quality and customer satisfaction.

HAPILA GmbH Questions

The HAPILA GmbH annual revenue was $5.3 million in 2026.

Uwe Müller is the Gründer und Geschäftsführer of HAPILA GmbH.

7 people are employed at HAPILA GmbH.

The NAICS codes for HAPILA GmbH are [32, 32541, 3254, 325].

The SIC codes for HAPILA GmbH are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users